Portola Pharmaceuticals (Portola Pharmaceuticals) Days Inventory : 81.08 (As of Mar. 2020)

View and export this data going back to 2013. Start your Free Trial

What is Portola Pharmaceuticals Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Portola Pharmaceuticals's Average Total Inventories for the three months ended in Mar. 2020 was $3.8 Mil. Portola Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2020 was $4.3 Mil. Hence, Portola Pharmaceuticals's Days Inventory for the three months ended in Mar. 2020 was 81.08.

The historical rank and industry rank for Portola Pharmaceuticals's Days Inventory or its related term are showing as below:

PTLA's Days Inventory is not ranked ^*
in the Biotechnology industry.
Industry Median: 189.69
* Ranked among companies with meaningful Days Inventory only.

Portola Pharmaceuticals's Days Inventory increased from Mar. 2019 (67.29) to Mar. 2020 (81.08). It might indicate that Portola Pharmaceuticals's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Portola Pharmaceuticals's Inventory Turnover for the three months ended in Mar. 2020 was 1.13.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Portola Pharmaceuticals's Inventory-to-Revenue for the three months ended in Mar. 2020 was 0.15.

Portola Pharmaceuticals Days Inventory Historical Data

The historical data trend for Portola Pharmaceuticals's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portola Pharmaceuticals Days Inventory Chart

Portola Pharmaceuticals Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Days Inventory

Get a 7-Day Free Trial

966.59

90.56

49.24

Portola Pharmaceuticals Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Days Inventory	Get a 7-Day Free Trial															67.29	38.57	66.36	9.97	81.08

Competitive Comparison of Portola Pharmaceuticals's Days Inventory

For the Biotechnology subindustry, Portola Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Portola Pharmaceuticals's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Portola Pharmaceuticals's Days Inventory distribution charts can be found below:

* The bar in red indicates where Portola Pharmaceuticals's Days Inventory falls into.

Portola Pharmaceuticals Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Portola Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2019 is calculated as

	Days Inventory (A: Dec. 2019 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2018 )	+	Total Inventories (A: Dec. 2019 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2019 )	*	Days in Period
=	( (7.873	+	4.101)	/	2 )	/	44.378	*	365
=	5.987					/	44.378	*	365
=	49.24

Portola Pharmaceuticals's Days Inventory for the quarter that ended in Mar. 2020 is calculated as:

	Days Inventory (Q: Mar. 2020 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2019 )	+	Total Inventories (Q: Mar. 2020 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2020 )	*	Days in Period
=	( (4.101	+	3.576)	/	2 )	/	4.32	*	365 / 4
=	3.8385					/	4.32	*	365 / 4
=	81.08

Portola Pharmaceuticals (NAS:PTLA) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Portola Pharmaceuticals's Inventory Turnover for the three months ended in Mar. 2020 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	4.32	/	3.8385
	=	1.13

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Portola Pharmaceuticals's Inventory to Revenue for the three months ended in Mar. 2020 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	3.8385	/	26.389
	=	0.15

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Portola Pharmaceuticals Days Inventory Related Terms

Thank you for viewing the detailed overview of Portola Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Portola Pharmaceuticals (Portola Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portola Pharmaceuticals Inc (NAS:PTLA) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

270 E. Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.portola.com

Portola Pharmaceuticals Inc is a biotechnology company focused on developing and commercializing novel therapeutics. The company focuses on areas of thrombosis, other hematologic disorders, and inflammation for patients who have limited or no approved treatment options. Portola focuses on biomarker or genetic approaches to clinical development that it believes will increase the probability of clinical, regulatory, and commercial success of first-in-class therapies. The company also uses collaborative agreements.

Executives

Dennis M Fenton	director
John B Moriarty	officer: EVP, General Counsel	ALEXION PHARMACEUTICALS, 352 KNOTTER DRIVE, CHESHIRE CT 06410
Hollings Renton	director
David C Stump	director
Ted W Love	director	C/O GLOBAL BLOOD THERAPEUTICS, INC., 400 EAST JAMIE COURT, SUITE 101, SOUTH SAN FRANCISCO CA 94080
John Johnson	director	DENDREON CORPORATION, 1301 2ND AVENUE, SEATTLE WA 98101
Jeffrey W Bird	director	755 PAGE MILL RD STE A-200, PALO ALTO CA 94304-1005
Henry Ward Wolff	director	6701 KAISER DRIVE, FREMONT CA 94555
J. Scott Garland	director, officer: President and CEO	210 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080
Laura Brege	director	C/O ONYX PHARMACEUTICALS, INC., 2100 POWELL STREET, EMERYVILLE CA 94608
Mardi Dier	officer: EVP and CFO	C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Rajiv Patni	officer: EVP, CMO	C/O OCERA THERAPEUTICS, INC., 525 UNIVERSITY AVENUE, SUITE 610, PALO ALTO CA 94301
John T Curnutte	officer: EVP R&D	PORTOLA PHARMACEUTICALS, INC., 270 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
Charles J Homcy	other: Former Director	PORTOLA PHARMACEUTICALS, INC., 270 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080
William Lis	director, officer: Chief Executive Officer	PORTOLA PHARMACEUTICALS, INC., 270 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080